Health

Research identifies RNA structures linked to Parkinson’s

HQ Team November 20, 2024: A team of researchers from Kumamoto University has found that unique RNA structures known as G-quadruplexes (G4s) facilitate.

Read More
Health

Personality traits influence physical activity and sedentary behavior

HQ team November 20, 2024: Your inclination to get up from the couch to go for a run or remain slouched there is.

Read More
Climate Health Medical

Pact to cut methane emissions from organic waste signed at COP29

More than 30 nations, which combined account for 47% of global methane emissions from organic waste, signed a pact to reduce levels by.

Read More
Health Medical Pharma

Sitting for 10.6 hours a day increases heart disease risk by 60%

A sedentary lifestyle of more than 10.6 hours a day increases heart disease by up to 60%, according to a study by Mass.

Read More
Health Uncategorized

EU regulators reverse course, approve Alzheimer’s drug Leqembi

HQ Team November 19, 2024: The European Medicines Agency (EMA) granted conditional approval for lecanemab, for the treatment of early Alzheimer’s disease in.

Read More
Health

Case for integrating artificial intelligence for clinical diagnosis process

HQ Team November 19, 2024: The emergence of AI technology as a diagnostic tool is slowly changing how health professionals view patient care..

Read More
Health

Shingles vaccines proposed for older adults to prevent cardiovascular risks

HQ Team November 16, 2024: Shingles vaccination has proven effective in preventing herpes zoster and its related complications. Recent research suggests that the.

Read More
Drugs Health Pharma

Measles cases surge worldwide, access to vaccine is ‘inadequate’: WHO

Measles cases worldwide have risen 20% year-on-year in 2023 to about 10.3 million due to inadequate access to vaccines, according to new estimates.

Read More
Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

Read More
Health

Lilly’s trial results for treating obesity and pre-diabetes are promising

HQ Team November 15, 2024: Eli Lilly’s Phase III trial has yielded positive results from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for.

Read More